Search research articles
Contact Us
Filters
Showing results (401-410 of 747) with videos related to
Page
of 75
Sort By:
Cell Death and Differentiation
|
April 15, 2022
Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Amar Balihodzic, Felix Prinz, Michael A Dengler, et al.
The Journal of Rheumatology
|
August 1, 1995
A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI)
S D Jones, J Porter, S L Garrett, et al.
Oncogene
|
August 16, 2023
Going circular: history, present, and future of circRNAs in cancer
Giuseppina Pisignano, David C Michael, Tanvi H Visal, et al.
Rheumatology (Oxford, England)
|
May 18, 1999
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial
M Dougados, A Gueguen, J P Nakache, et al.
The Journal of Rheumatology
|
January 5, 2002
Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors
S Brophy, S Pavy, P Lewis, et al.
RNA Biology
|
December 19, 2019
Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum
Selin Oncul, Paola Amero, Cristian Rodriguez-Aguayo, et al.
Frontiers in Cell and Developmental Biology
|
October 12, 2020
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers
Dominik A Barth, Rares Drula, Leonie Ott, et al.
Molecular Aspects of Medicine
|
September 28, 2019
MiR-200 family and cancer: From a meta-analysis view
Guo-Liang Huang, Jiancong Sun, Yan Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 31, 2019
MicroRNA based theranostics for brain cancer: basic principles
George E D Petrescu, Alexandru A Sabo, Ligia I Torsin, et al.
Cancers
|
December 16, 2020
Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance
Patrick J Hunt, Katherine E Kabotyanski, George A Calin, et al.
Page
of 75
Search research articles
Search
Showing results (401-410 of 747) with videos related to
Sort By:
Page
of 75
Cell Death and Differentiation
|
April 15, 2022
Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Amar Balihodzic, Felix Prinz, Michael A Dengler, et al.
The Journal of Rheumatology
|
August 1, 1995
A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI)
S D Jones, J Porter, S L Garrett, et al.
Oncogene
|
August 16, 2023
Going circular: history, present, and future of circRNAs in cancer
Giuseppina Pisignano, David C Michael, Tanvi H Visal, et al.
Rheumatology (Oxford, England)
|
May 18, 1999
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial
M Dougados, A Gueguen, J P Nakache, et al.
The Journal of Rheumatology
|
January 5, 2002
Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors
S Brophy, S Pavy, P Lewis, et al.
RNA Biology
|
December 19, 2019
Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum
Selin Oncul, Paola Amero, Cristian Rodriguez-Aguayo, et al.
Frontiers in Cell and Developmental Biology
|
October 12, 2020
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers
Dominik A Barth, Rares Drula, Leonie Ott, et al.
Molecular Aspects of Medicine
|
September 28, 2019
MiR-200 family and cancer: From a meta-analysis view
Guo-Liang Huang, Jiancong Sun, Yan Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 31, 2019
MicroRNA based theranostics for brain cancer: basic principles
George E D Petrescu, Alexandru A Sabo, Ligia I Torsin, et al.
Cancers
|
December 16, 2020
Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance
Patrick J Hunt, Katherine E Kabotyanski, George A Calin, et al.
Page
of 75